Diverse Provider Network
Patient data is normalized and de-identified from numerous electronic health records across NCI-designated cancer centers, academic medical centers, and community-based hospitals
Rich Clinical Data
Our customized natural language processing organizes clinical data pulled from multiple electronic medical records, including progress notes, path reports, and radiology scans/reports
Deep Genomic Data
DNA and RNA based alterations are captured via next-generation sequencing and immunotherapy metrics are clinically measured for patient cases
Partners leverage our large and growing database of clinical and molecular data to analyze thousands of variables across DNA and RNA targets to identify biomarker signatures linked to super responders or non-responders.
CLINICAL TRIAL DEVELOPMENT
We facilitate intelligent trial design powered by clinical and molecular data, identifying the right trial characteristics for the right locations to accelerate enrollment and improve trial outcomes. In addition, we can use real-world evidence to support synthetic control arms.
Tempus can build data sets of clinical and molecular data at an unprecedented rate to create proprietary data sets for analysis across a wide variety of patient cohorts.
As an exclusive licensee to ASCO, the American Society of Clinical Oncology, and CancerLinQ, an ASCO nonprofit subsidiary and health information technology platform that works with over 2,000 medical oncologists across over a million cancer patient records to date, Tempus will accelerate development and delivery of high quality, de-identified clinical databases for use by the broader cancer community.